SCHEMBL4119115

SCHEMBL4119115

COC(=O)c1cccc(C(F)(F)F)c1OC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSS P25774 1/20 0.56
LMNA P02545 2/20 0.45
GAA P10253 2/20 0.45
TSHR P16473 1/20 0.44
CFTR P13569 5/20 0.44
PDK2 Q15119 2/20 0.43
ALDH1A1 P00352 3/20 0.43
HSD17B10 Q99714 1/20 0.43
NOTUM Q6P988 1/20 0.43
KDM4E B2RXH2 3/20 0.43
RBP4 P02753 1/20 0.43
MAOB P27338 1/20 0.43
TAS2R14 Q9NYV8 1/20 0.42
POLB P06746 1/20 0.42
ATM Q13315 1/20 0.42
HPGD P15428 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
PDK1 Q15118 1/20 0.42
PDK3 Q15120 1/20 0.42
PDK4 Q16654 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27803203 0.86 CTSS (0.44) CTSSLMNAGAATSHRCFTR
SCHEMBL4123848 0.85 CTSS (0.54) CTSSLMNAGAAALDH1A1HSD17B10
SCHEMBL6024762 0.84 CTSS (0.61) CTSSLMNAGAACFTRPDK2
SCHEMBL17339302 0.83 CTSS (0.53) CTSSLMNAGAAALDH1A1KDM4E
SCHEMBL4195950 0.83 CTSS (0.53) CTSSLMNAGAAMAOBTAS2R14
SCHEMBL45490 0.82 LMNA (0.59) LMNAGAATSHRCFTRPDK2
SCHEMBL23817448 0.82 CTSS (0.47) CTSSALDH1A1KDM4ETAS2R14HPGD
SCHEMBL3511611 0.82 TSHR (0.57) LMNAGAATSHRCFTRALDH1A1
SCHEMBL726068 0.81 TAS2R14 (0.54) CTSSLMNAGAATSHRCFTR
SCHEMBL5239843 0.81 CTSS (0.51) CTSSLMNAGAATSHRCFTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
EP-1939205-A1 TRICYCLIC COMPOUND Daiichi Sankyo Company, Limited (JP) 2008-07-02 EP disclosed
EP-1939205-A1 TRICYCLIC COMPOUND Daiichi Sankyo Company, Limited (JP) 2008-07-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181942-A1 TRICYCLIC COMPOUNDS FDFT1, COASY, HMGCR CTSS 610/4885LMNA 1109/4885GAA 922/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.